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As much of my work is collaborative,
I am very aware of the virtues and
difficulties of collaboration in the
modern scientific world. Most
collaborations are short term; perhaps
one scientist has an assay, the other a
reagent, and an obvious quick gain
will result from joining forces. But
greater (though often less concrete)
benefits come from longer term
collaborations. Your collaborator may
be the one person you trust to tell
you if your ideas are nonsense, or the
person you call for advice when
you’re barricaded in your office
hiding from your students. The
hallowed halls of the biology hall of
fame ring with the rhythms of
famous names in pairs: Watson and
Crick, Bishop and Varmus, Brown
and Goldstein, Nüsslein-Volhard and
Weischaus. The productivity of these
pairings make the benefits of
collaboration clear. Why, then, are
true collaborations between
scientists of equal stature so rare? 
Laboratories tend to have an
island mentality; the group leader
sits alone at the top of a pyramid,
waiting for a student or postdoc to
produce something for them to talk
about at the next meeting.
Interactions between these small
kingdoms are infrequent, and their
rules are set well in advance. “The
paper has to be from my lab because
the reagents are mine” or “you can
be on the paper if you show us how
to do your assay” are conditions that
are frequently made before any
experiments are done. When the
paper becomes reality, the lab heads
rarely say “that was great, let’s go on
collaborating”. Instead, they often
use what they learned in the
collaboration to compete with each
other. This view of the world is sour,
but it’s based on experience. 
What are the pressures that
induce such behaviour? Of course, it
all boils down to credit. Who did the
most, where did the idea come from?
Is the benefit of collaborating larger
than the loss of credit that results?
Division of credit is never more
fraught than when work is prepared
for publication. First you discuss how
to eliminate as many authors as
possible. Then you argue bitterly
over who should be first author, who
last. This journal, when starting to
take research papers, even proposed
that each author should provide a
description of their contribution to
the research in the paper. (Bloggs did
all the work while Smith made the
tea, for example). 
How far we have come from the
original system used by the Royal
Society, in which the names of all
those associated with the work were
listed alphabetically. Perhaps we
should give each author a credit
percentage, so that assessing the
lifetime contribution of an individual
just requires you to add up his or her
total score. Or we could adopt the
patented Hyman two-dimensional
system, which allows you to have as
many first and last authors as you
like, and looks like this:
First authors Middle authors Last authors
Green, J. Bloggs, P. Boss, B.
Newman, X. Noggin, Q. King, R.
The anxiety over apportioning
credit arises because individual
productivity is the only thing that the
system values. Jobs are given and
tenure granted for the total output of
papers. A side-effect is that the
people who used to stimulate
everyone in the lab to do ground-
breaking experiments, but were too
busy talking (and drinking tea) to do
any experiments themselves, are a
dying breed. 
In some US universities, papers
done in collaboration are not counted
toward tenure decisions. When I first
heard this, I could not believe it.
This system seems to me to select for
people who like to have a miserable
time doing science and prefer to slow
down progress, to enhance their own
credit. In this respect I feel fortunate
to be at EMBL, where, when your
contract comes up for renewal, it is a
bad sign if you have published no
papers in collaboration. 
The truth is that no laboratory is
an island. Modern biology is a huge
enterprise that collects and integrates
information from many different
systems. It is very doubtful that any
of us will be remembered as a
scientific giant, in the same category
as Einstein or Faraday, yet the
selection against collaboration as a
criterion for success means that we
spend our whole lives worrying about
credit with little to show for it in the
end. Each lab is judged by “output”,
instead of by its overall contribution
to science, surely a terrible thing.
Although modern biology is an
industry, the way we go about it is
preindustrial; our labs are a collection
of small cottage industries, each of
which tries to place an individual
stamp on the product, like weavers
putting out their own special designs.
Limited collaboration is relatively
easy — one person may dye the wool
while another weaves (though a dyer,
even one who develops a new process
and makes new colours possible, runs
the risk of being labeled as a
technician). Getting two weavers
together is much more difficult. But
in my experience, once the initial
difficulties are overcome, long-term
collaborations are extremely fruitful
for both parties. Two people working
together seem to provide more than
the sum of two brains, allowing a
sharing of knowledge and experience
far beyond what’s normally possible. 
Alan Sawyer read this column for
me, so he gets 2% of the credit. 
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